Drugs Controller General of India (DCGI)

Hyderabad: Vaccine maker Biological E. Ltd on Tuesday announced that its Covid-19 vaccine Corbevax has received a nod from the Drugs Controller General of India (DCGI) for emergency use authorisation for the 5-12-year age group. The…

New-Delhi: The Drugs Controller General of India (DCGI) on Thursday granted conditional market approval for Covishield and Covaxin. However, it is important to note that the market approval does not mean that the vaccines will be…

Hyderabad: Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine, sources said on Monday. The Hyderabad-based vaccine maker has submitted the…

New-Delhi: Serum Institute of India (SII) has sought from DCGI India, for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus Omicron…

New Delhi: Russia's single-dose Sputnik Light Covid-19 vaccine will be launched in India by December, 2021, said Kirill Dmitriev, CEO, Russian Direct Investment Fund (RDIF) in a webinar on Wednesday. The Drugs Controller General of India…

New Delhi: The Drugs Controller General of India (DCGI) has granted permission for the conducting of the Phase III bridging trials of Sputnik Light on the Indian population. The Sputnik Light is a single-dose Covid-19 vaccine of the Russian…

New-Delhi: The Drugs Controller General of India (DCGI) has given its approval for a study on mixing of Covaxin and Covishield Covid-19 vaccines in India. This study and its clinical trials will be conducted by Christian Medical College,…

Hyderabad:  Sputnik Light, the single-dose Covid-19 vaccine, can submit Russian safety data for approval in India, Dr Reddy's Laboratories said on Thursday. The Hyderabad-based Dr Reddy's, in a statement, said that the Subject Expert…